SAM
BRLI

Shell Asset Management’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Shell Asset Management’s Portfolio BRLI Stock Details BRLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-6,871
Closed -$193K – 994
2015
Q3 		$193K Buy
6,871
+323
+5% +$13.6K ﹤0.01% 791
2015
Q2 		$270K Sell
6,548
-303
-4% -$10.9K 0.01% 823
2015
Q1 		$241K Sell
6,851
-20
-0.3% -$677 ﹤0.01% 816
2014
Q4 		$221K Hold
6,871
– – ﹤0.01% 825
2014
Q3 		$193K Buy
6,871
+647
+10% +$19.7K ﹤0.01% 819
2014
Q2 		$188K Sell
6,224
-72
-1% -$1.99K ﹤0.01% 833
2014
Q1 		$174K Sell
6,296
-112,204
-95% -$2.94M ﹤0.01% 810
2013
Q4 		$3.03M Buy
118,500
+19,144
+19% +$590K 0.05% 347
2013
Q3 		$2.97M Hold
99,356
– – 0.05% 364
2013
Q2 		$2.86M Buy
+99,356
New +$2.74M 0.05% 357

Shell Asset Management's BRLI Position: Q4 2015 in Review

Shell Asset Management sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q4 2015, closing a stake of 6,871 shares — an estimated $193K sold.

Shell Asset Management first reported a position in BRLI in Q2 2013 and held it in 10 quarters. The position peaked at $3.03M in Q4 2013. 0 funds tracked by Wall St. Rank hold BRLI as of Q4 2015.

  • Shell Asset Management reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q4 2015 after selling out during the quarter.
  • Shell Asset Management sold 6,871 BIO-REFERENCE LABS INC-NEW- shares in Q4 2015, an estimated $193K.
  • Shell Asset Management first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2013 and held it in 10 quarters.
  • Shell Asset Management's BIO-REFERENCE LABS INC-NEW- position peaked at $3.03M in Q4 2013.
  • 0 funds tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q4 2015.

Based on Shell Asset Management's 13F filing for Q4 2015, filed 5 Feb 2016.